Literature DB >> 22682781

Categorical vs dimensional classifications of psychotic disorders.

Melissa Potuzak1, Caitlin Ravichandran, Kathryn E Lewandowski, Dost Ongür, Bruce M Cohen.   

Abstract

OBJECTIVE: Both categorical and dimensional methods appear relevant to classifying psychotic disorders; however, there is no clear consensus on the most appropriate categories and dimensions or on the best approach for constructing nosologic criteria that integrate these 2 methods. This review examines the evidence on specific dimensions and categories that would best characterize psychoses.
METHOD: Entries in the MEDLINE database between 1980 and 2011 were searched for studies of the dimensional and/or categorical structure of psychosis. Studies were included if samples represented a spectrum of psychotic disorders and dimensions/categories were empirically derived using principal components analysis, factor analysis, or latent class analysis.
RESULTS: Most dimensional studies observed 4 or 5 dimensions within psychosis, with positive, negative, disorganization, and affective symptom domains most frequently reported. Substance abuse, anxiety, early onset/developmental, insight, cognition, hostility, and behavioral/social disturbance dimensions appeared in some studies. Categorical studies suggested 3 to 7 major classes within psychosis, including a class similar to Kraepelin's dementia praecox and one or more classes with significant mood components. Only 2 studies compared the relative fit of empirically derived dimensions and categories within the same data set, and each had significant limitations.
CONCLUSION: There is relatively consistent evidence on appropriate categories and dimensions for characterizing psychoses. However, the lack of studies directly comparing or combining these approaches provides insufficient evidence for definitive conclusions about their relative merits and integration. The authors provide specific recommendations for designing future studies to identify valid dimensions and/or categories of the psychoses and investigate hybrid approaches to model the structure of the underlying illnesses.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22682781      PMCID: PMC3488145          DOI: 10.1016/j.comppsych.2012.04.010

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  66 in total

1.  Familiality of symptom dimensions in schizophrenia.

Authors:  H Wickham; C Walsh; P Asherson; C Taylor; T Sigmundson; M Gill; M J Owen; P McGuffin; R Murray; P Sham
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Meta-analysis of symptom factors in schizophrenia.

Authors:  B S Grube; R M Bilder; R S Goldman
Journal:  Schizophr Res       Date:  1998-05-25       Impact factor: 4.939

3.  A factor model of the functional psychoses and the relationship of factors to clinical variables and brain morphology.

Authors:  A M McIntosh; A Forrester; S M Lawrie; M Byrne; A Harper; J N Kestelman; J J Best; E C Johnstone; D G Owens
Journal:  Psychol Med       Date:  2001-01       Impact factor: 7.723

4.  Five latent factors underlying schizophrenia: analysis and relationship to illnesses in relatives.

Authors:  John A McGrath; Gerald Nestadt; Kung-Yee Liang; Virginia K Lasseter; Paula S Wolyniec; M Danielle Fallin; Mary H Thornquist; James R Luke; Ann E Pulver
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

5.  Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders.

Authors:  V Peralta; M J Cuesta
Journal:  Schizophr Res       Date:  1999-07-27       Impact factor: 4.939

6.  Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses.

Authors:  V Murray; I McKee; P M Miller; D Young; W J Muir; A J Pelosi; D H R Blackwood
Journal:  Psychol Med       Date:  2005-04       Impact factor: 7.723

7.  Dimensions of depression, mania and psychosis in the general population.

Authors:  L Krabbendam; I Myin-Germeys; R De Graaf; W Vollebergh; W A Nolen; J Iedema; J Van Os
Journal:  Psychol Med       Date:  2004-10       Impact factor: 7.723

8.  Symptom factors in early-onset psychotic disorders.

Authors:  Jon McClellan; Chris McCurry; Matthew L Speltz; Karen Jones
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-07       Impact factor: 8.829

Review 9.  The dimensionality of schizophrenia concepts in first-episode psychosis.

Authors:  R C Bell; P Dudgeon; P D McGorry; H J Jackson
Journal:  Acta Psychiatr Scand       Date:  1998-05       Impact factor: 6.392

10.  Symptoms of psychoses. A factor-analytic study.

Authors:  T Kitamura; Y Okazaki; A Fujinawa; M Yoshino; Y Kasahara
Journal:  Br J Psychiatry       Date:  1995-02       Impact factor: 9.319

View more
  11 in total

Review 1.  Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Authors:  Sabina Berretta; Stephan Heckers; Francine M Benes
Journal:  Schizophr Res       Date:  2014-11-11       Impact factor: 4.939

2.  Symptom dimensions and subgroups in childhood-onset schizophrenia.

Authors:  Kirsten E S Craddock; Xueping Zhou; Siyuan Liu; Peter Gochman; Dwight Dickinson; Judith L Rapoport
Journal:  Schizophr Res       Date:  2017-11-13       Impact factor: 4.939

3.  Symptom rating scales for schizophrenia and other primary psychotic disorders in ICD-11.

Authors:  J W Keeley; W Gaebel
Journal:  Epidemiol Psychiatr Sci       Date:  2017-06-19       Impact factor: 6.892

4.  Bipolar disorder risk gene FOXO6 modulates negative symptoms in schizophrenia: a neuroimaging genetics study.

Authors:  Joseph J Shenker; Sarojini M Sengupta; Ridha Joober; Ashok Malla; M Mallar Chakravarty; Martin Lepage
Journal:  J Psychiatry Neurosci       Date:  2017-05       Impact factor: 6.186

5.  Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration.

Authors:  Dan J Stein; Steven J Shoptaw; Daniel V Vigo; Crick Lund; Pim Cuijpers; Jason Bantjes; Norman Sartorius; Mario Maj
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

6.  The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders.

Authors:  Anna Alkelai; Lior Greenbaum; Anna R Docherty; Andrey A Shabalin; Gundula Povysil; Ayan Malakar; Daniel Hughes; Shannon L Delaney; Emma P Peabody; James McNamara; Sahar Gelfman; Evan H Baugh; Anthony W Zoghbi; Matthew B Harms; Hann-Shyan Hwang; Anat Grossman-Jonish; Vimla Aggarwal; Erin L Heinzen; Vaidehi Jobanputra; Ann E Pulver; Bernard Lerer; David B Goldstein
Journal:  Mol Psychiatry       Date:  2021-11-19       Impact factor: 13.437

7.  Heterogeneity and Classification of Recent Onset Psychosis and Depression: A Multimodal Machine Learning Approach.

Authors:  Paris Alexandros Lalousis; Stephen J Wood; Lianne Schmaal; Katharine Chisholm; Sian Lowri Griffiths; Renate L E P Reniers; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Joseph Kambeitz; Rebekka Lencer; Christos Pantelis; Stephan Ruhrmann; Raimo K R Salokangas; Frauke Schultze-Lutter; Carolina Bonivento; Dominic Dwyer; Adele Ferro; Theresa Haidl; Marlene Rosen; Andre Schmidt; Eva Meisenzahl; Nikolaos Koutsouleris; Rachel Upthegrove
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

Review 8.  Focus on psychosis.

Authors:  Wolfgang Gaebel; Jürgen Zielasek
Journal:  Dialogues Clin Neurosci       Date:  2015-03       Impact factor: 5.986

9.  Metacognitive training for delusions (MCTd): effectiveness on data-gathering and belief flexibility in a Chinese sample.

Authors:  Suzanne Ho-Wai So; Arthur P Chan; Catherine Shiu-Yin Chong; Melissa Hiu-Mei Wong; William Tak-Lam Lo; Dicky Wai-Sau Chung; Sandra S Chan
Journal:  Front Psychol       Date:  2015-06-15

10.  Early onset first episode psychosis: dimensional structure of symptoms, clinical subtypes and related neurodevelopmental markers.

Authors:  Maria Giuseppina Petruzzelli; Lucia Margari; Andrea Bosco; Francesco Craig; Roberto Palumbi; Francesco Margari
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-07-26       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.